Universal immunity to influenza must outwit immune evasion.
Identifieur interne : 000098 ( PubMed/Corpus ); précédent : 000097; suivant : 000099Universal immunity to influenza must outwit immune evasion.
Auteurs : Sergio Qui Ones-Parra ; Liyen Loh ; Lorena E. Brown ; Katherine Kedzierska ; Sophie A. ValkenburgSource :
- Frontiers in microbiology [ 1664-302X ] ; 2014.
Abstract
Although an influenza vaccine has been available for 70 years, influenza virus still causes seasonal epidemics and worldwide pandemics. Currently available vaccines elicit strain-specific antibody (Ab) responses to the surface haemagglutinin (HA) and neuraminidase (NA) proteins, but these can be ineffective against serologically-distinct viral variants and novel subtypes. Thus, there is a great need for cross-protective or "universal" influenza vaccines to overcome the necessity for annual immunization against seasonal influenza and to provide immunity to reduce the severity of infection with pandemic or outbreak viruses. It is well established that natural influenza infection can provide cross-reactive immunity that can reduce the impact of infection with distinct influenza type A strains and subtypes, including H1N1, H3N2, H2N2, H5N1, and H7N9. The key to generating universal influenza immunity through vaccination is to target functionally-conserved regions of the virus, which include epitopes on the internal proteins for cross-reactive T cell immunity or on the HA stem for broadly reactive Ab responses. In the wake of the 2009 H1N1 pandemic, broadly neutralizing antibodies (bnAbs) have been characterized and isolated from convalescent and vaccinated individuals, inspiring development of new vaccination techniques to elicit such responses. Induction of influenza-specific T cell responses through vaccination has also been recently examined in clinical trials. Strong evidence is available from human and animal models of influenza to show that established influenza-specific T cell memory can reduce viral shedding and symptom severity. However, the published evidence also shows that CD8(+) T cells can efficiently select immune escape mutants early after influenza virus infection. Here, we discuss universal immunity to influenza viruses mediated by both cross-reactive T cells and Abs, the mechanisms of immune evasion in influenza, and propose how to counteract commonly occurring immune-escape variants.
DOI: 10.3389/fmicb.2014.00285
PubMed: 24971078
Links to Exploration step
pubmed:24971078Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Universal immunity to influenza must outwit immune evasion.</title>
<author><name sortKey="Qui Ones Parra, Sergio" sort="Qui Ones Parra, Sergio" uniqKey="Qui Ones Parra S" first="Sergio" last="Qui Ones-Parra">Sergio Qui Ones-Parra</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Loh, Liyen" sort="Loh, Liyen" uniqKey="Loh L" first="Liyen" last="Loh">Liyen Loh</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Brown, Lorena E" sort="Brown, Lorena E" uniqKey="Brown L" first="Lorena E" last="Brown">Lorena E. Brown</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kedzierska, Katherine" sort="Kedzierska, Katherine" uniqKey="Kedzierska K" first="Katherine" last="Kedzierska">Katherine Kedzierska</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Valkenburg, Sophie A" sort="Valkenburg, Sophie A" uniqKey="Valkenburg S" first="Sophie A" last="Valkenburg">Sophie A. Valkenburg</name>
<affiliation><nlm:affiliation>Centre for Influenza Research and School of Public Health, The University of Hong Kong Hong Kong, China.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24971078</idno>
<idno type="pmid">24971078</idno>
<idno type="doi">10.3389/fmicb.2014.00285</idno>
<idno type="wicri:Area/PubMed/Corpus">000098</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000098</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Universal immunity to influenza must outwit immune evasion.</title>
<author><name sortKey="Qui Ones Parra, Sergio" sort="Qui Ones Parra, Sergio" uniqKey="Qui Ones Parra S" first="Sergio" last="Qui Ones-Parra">Sergio Qui Ones-Parra</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Loh, Liyen" sort="Loh, Liyen" uniqKey="Loh L" first="Liyen" last="Loh">Liyen Loh</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Brown, Lorena E" sort="Brown, Lorena E" uniqKey="Brown L" first="Lorena E" last="Brown">Lorena E. Brown</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Kedzierska, Katherine" sort="Kedzierska, Katherine" uniqKey="Kedzierska K" first="Katherine" last="Kedzierska">Katherine Kedzierska</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Valkenburg, Sophie A" sort="Valkenburg, Sophie A" uniqKey="Valkenburg S" first="Sophie A" last="Valkenburg">Sophie A. Valkenburg</name>
<affiliation><nlm:affiliation>Centre for Influenza Research and School of Public Health, The University of Hong Kong Hong Kong, China.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Frontiers in microbiology</title>
<idno type="ISSN">1664-302X</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Although an influenza vaccine has been available for 70 years, influenza virus still causes seasonal epidemics and worldwide pandemics. Currently available vaccines elicit strain-specific antibody (Ab) responses to the surface haemagglutinin (HA) and neuraminidase (NA) proteins, but these can be ineffective against serologically-distinct viral variants and novel subtypes. Thus, there is a great need for cross-protective or "universal" influenza vaccines to overcome the necessity for annual immunization against seasonal influenza and to provide immunity to reduce the severity of infection with pandemic or outbreak viruses. It is well established that natural influenza infection can provide cross-reactive immunity that can reduce the impact of infection with distinct influenza type A strains and subtypes, including H1N1, H3N2, H2N2, H5N1, and H7N9. The key to generating universal influenza immunity through vaccination is to target functionally-conserved regions of the virus, which include epitopes on the internal proteins for cross-reactive T cell immunity or on the HA stem for broadly reactive Ab responses. In the wake of the 2009 H1N1 pandemic, broadly neutralizing antibodies (bnAbs) have been characterized and isolated from convalescent and vaccinated individuals, inspiring development of new vaccination techniques to elicit such responses. Induction of influenza-specific T cell responses through vaccination has also been recently examined in clinical trials. Strong evidence is available from human and animal models of influenza to show that established influenza-specific T cell memory can reduce viral shedding and symptom severity. However, the published evidence also shows that CD8(+) T cells can efficiently select immune escape mutants early after influenza virus infection. Here, we discuss universal immunity to influenza viruses mediated by both cross-reactive T cells and Abs, the mechanisms of immune evasion in influenza, and propose how to counteract commonly occurring immune-escape variants. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24971078</PMID>
<DateCompleted><Year>2014</Year>
<Month>06</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-302X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>5</Volume>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in microbiology</Title>
<ISOAbbreviation>Front Microbiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Universal immunity to influenza must outwit immune evasion.</ArticleTitle>
<Pagination><MedlinePgn>285</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fmicb.2014.00285</ELocationID>
<Abstract><AbstractText>Although an influenza vaccine has been available for 70 years, influenza virus still causes seasonal epidemics and worldwide pandemics. Currently available vaccines elicit strain-specific antibody (Ab) responses to the surface haemagglutinin (HA) and neuraminidase (NA) proteins, but these can be ineffective against serologically-distinct viral variants and novel subtypes. Thus, there is a great need for cross-protective or "universal" influenza vaccines to overcome the necessity for annual immunization against seasonal influenza and to provide immunity to reduce the severity of infection with pandemic or outbreak viruses. It is well established that natural influenza infection can provide cross-reactive immunity that can reduce the impact of infection with distinct influenza type A strains and subtypes, including H1N1, H3N2, H2N2, H5N1, and H7N9. The key to generating universal influenza immunity through vaccination is to target functionally-conserved regions of the virus, which include epitopes on the internal proteins for cross-reactive T cell immunity or on the HA stem for broadly reactive Ab responses. In the wake of the 2009 H1N1 pandemic, broadly neutralizing antibodies (bnAbs) have been characterized and isolated from convalescent and vaccinated individuals, inspiring development of new vaccination techniques to elicit such responses. Induction of influenza-specific T cell responses through vaccination has also been recently examined in clinical trials. Strong evidence is available from human and animal models of influenza to show that established influenza-specific T cell memory can reduce viral shedding and symptom severity. However, the published evidence also shows that CD8(+) T cells can efficiently select immune escape mutants early after influenza virus infection. Here, we discuss universal immunity to influenza viruses mediated by both cross-reactive T cells and Abs, the mechanisms of immune evasion in influenza, and propose how to counteract commonly occurring immune-escape variants. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quiñones-Parra</LastName>
<ForeName>Sergio</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Loh</LastName>
<ForeName>Liyen</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Brown</LastName>
<ForeName>Lorena E</ForeName>
<Initials>LE</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kedzierska</LastName>
<ForeName>Katherine</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Valkenburg</LastName>
<ForeName>Sophie A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo><Affiliation>Centre for Influenza Research and School of Public Health, The University of Hong Kong Hong Kong, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>06</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Front Microbiol</MedlineTA>
<NlmUniqueID>101548977</NlmUniqueID>
<ISSNLinking>1664-302X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">T cells memory</Keyword>
<Keyword MajorTopicYN="N">antibodies</Keyword>
<Keyword MajorTopicYN="N">influenza viruses</Keyword>
<Keyword MajorTopicYN="N">vaccine design</Keyword>
<Keyword MajorTopicYN="N">viral escape mechanisms</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>03</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>05</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>6</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24971078</ArticleId>
<ArticleId IdType="doi">10.3389/fmicb.2014.00285</ArticleId>
<ArticleId IdType="pmc">PMC4054793</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nat Commun. 2013;4:2663</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24173108</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2012 Dec 15;186(12):1292-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23087026</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2009 Dec 15;183(12):7919-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19933869</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Jan;72(1):882-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9420305</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2002 Dec;76(23):12388-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12414983</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2012 Jul 30;209(8):1391-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22851641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2013 Aug 28;5(200):200ra114</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23986398</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1986 Oct 1;164(4):1114-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2944982</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2012 Jan 29;18(2):274-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22286307</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Aug;74(15):6800-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10888619</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2011 Aug 15;187(4):1692-701</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21742967</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 Aug 12;333(6044):850-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21798894</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2010 May;120(5):1663-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20389023</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1977 Mar 3;266(5597):52-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">840296</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Jun;82(11):5161-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18353950</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6074-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15831586</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Apr;87(8):4728-37</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23408625</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Cell Biol. 2013 Feb;91(2):184-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23399741</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2006 Jan 1;193(1):49-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16323131</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2012 Dec;12(12):845-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23154222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1998 Jul;72(7):5648-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9621023</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Dec;87(24):13706-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24109221</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2011 Jan 1;52(1):1-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21148512</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2007 Jan 15;178(2):1030-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17202366</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2012 Nov 29;491(7426):717-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23051753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Nov;85(22):11995-2000</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21880755</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1981 May;126(5):1814-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7217668</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1996 Feb;70(2):1288-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8551597</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2013 Feb 15;190(4):1837-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23319732</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2009 Sep 24;361(13):1260-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19776407</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2014 Feb;20(2):143-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24412922</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 1983 Oct 1;2(8353):762-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6137602</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2011 Apr 1;186(7):4331-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21357542</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):11143-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12954978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2008 Sep 15;181(6):4168-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18768874</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2012 Sep 14;337(6100):1343-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22878502</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 2011 Jul 4;208(7):1511-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21708931</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1999 Apr 1;162(7):4163-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10201942</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1993 May;67(5):2552-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7682624</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1978 May 18;273(5659):238-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">306072</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1983 Jul 7;309(1):13-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6602294</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 1983 Apr 15;126(1):106-16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6189287</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2013 Jan 1;190(1):296-306</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23197262</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1990 May 15;144(10):3980-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1692070</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Feb;88(3):1684-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24257602</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2010 Jul;91(Pt 7):1743-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20335492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2011 Feb;11(2):131-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21267014</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 Sep;79(17):11239-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16103176</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Leukoc Biol. 2012 Mar;91(3):357-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22003207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2008 Dec;82(24):12241-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18842709</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2004 Feb 15;172(4):2453-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14764717</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann N Y Acad Sci. 1988;532:230-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2845845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8597-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10411921</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1990 Aug 16;346(6285):629-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1696684</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Immunol. 2013 Mar;10(2):159-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23353835</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2005 May;79(9):5721-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15827187</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1988 Dec 1;168(6):2045-57</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3264322</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2011 May 31;108(22):9178-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21562214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Leukoc Biol. 2012 Jul;92(1):83-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22362872</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1984 Feb 1;159(2):365-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6198430</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2012 Aug;122(8):2847-56</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22820287</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12599-604</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20616031</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2013 Oct;19(10 ):1305-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24056771</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2010 May 18;1(1):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20689752</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 1993 Mar 19;259(5102):1745-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8456302</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2009 Apr 10;324(5924):246-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19251591</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2002 May 24;296(5572):1439-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12029127</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 2008 May;28(5):710-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18468462</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2013 Sep;9(9):e1003615</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24068930</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2005 Jun;86(Pt 6):1801-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15914859</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2012 Feb;8(2):e1002544</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22383879</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2003 Jun 2;21(19-20):2616-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12744898</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2013 Feb 7;121(6):951-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23255555</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2010 Aug 27;329(5995):1060-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20647428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tohoku J Exp Med. 1979 Jul;128(3):241-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">494246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(2):e31535</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22363665</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2009 Mar;5(3):e1000350</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19300497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2006 Dec;80(23):11756-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16971435</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21825125</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2012 Sep 27;489(7417):526-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22982990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunity. 1998 Jun;8(6):683-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9655482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2005 Nov 16;23(46-47):5404-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16011865</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Feb;88(4):2340-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24307585</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Cell Biol. 2014 Apr;92(4):377-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24394993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1997 Dec 1;159(11):5197-200</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9548456</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1985 Mar;82(6):1785-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3872457</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Immunol. 2013 Jan;10(1):13-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23085946</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19918065</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2011 May 15;186(10):5590-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21490153</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2009 Sep 15;200(6):858-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19656068</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2011 Apr 10;412(2):297-305</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21315402</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1992 Apr 1;175(4):1143-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1552285</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Immunol. 2013 Feb;13(2):88-100</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23348415</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Biol Chem. 2012 Mar 16;287(12):8816-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22294696</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2013 Feb 14;121(7):1124-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23243281</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2012 Oct;86(19):10302-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22787225</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(10):e48322</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23118984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2000 Dec;74(24):11690-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11090168</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1997 Dec 15;186(12):2063-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9396777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1986 Jul;58(3):417-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2426185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Immunol. 2004 Sep;5(9):927-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15300249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):540-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19122146</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 1999 Oct;5(10):1157-63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10502819</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1991 Jul;72 ( Pt 7):1695-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1677414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1998 Jan 1;160(1):322-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9551987</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Annu Rev Immunol. 2013;31:705-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23330954</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2013 Jul 4;499(7456):102-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23698367</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Vaccine Immunol. 2008 Jul;15(7):1042-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18448618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1977 Sep 1;146(3):673-89</Citation>
<ArticleIdList><ArticleId IdType="pubmed">302303</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2013 Nov 21;503(7476):406-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24141948</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2013 Mar 13;5(176):176ra32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23486778</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Jul;84(13):6527-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20410263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2011 Jan 27;8:44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21272360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2012 Jul;55(1):19-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22441650</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18979-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20956293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Invest. 2008 Oct;118(10 ):3478-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18802496</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2011 Aug 12;333(6044):843-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21737702</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 2013 Mar;94(Pt 3):583-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23152369</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1049-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24395804</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3330-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19211791</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000098 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000098 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= H2N2V1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:24971078 |texte= Universal immunity to influenza must outwit immune evasion. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24971078" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a H2N2V1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |